• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰在新冠疫情前和疫情期间经皮冠状动脉介入治疗后的住院和 30 天死亡率。

In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention in England in the Pre-COVID and COVID Eras.

机构信息

Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, UK.

出版信息

J Invasive Cardiol. 2021 Mar;33(3):E206-E219. doi: 10.25270/jic/20.00639. Epub 2020 Dec 22.

DOI:10.25270/jic/20.00639
PMID:33348315
Abstract

BACKGROUND

Public reporting of percutaneous coronary intervention (PCI) outcomes is a performance metric and a requirement in many healthcare systems. There are inconsistent data on the causes of death after PCI, and the proportion of these deaths that are attributable to cardiac causes.

METHODS

All patients undergoing PCI in England between January 1, 2017 and May 10, 2020 (n = 273,141) were retrospectively analyzed according to their outcome from the date of PCI: no death, in-hospital death, postdischarge death, and total 30-day death. The present study examined short-term primary causes of death after PCI in a national cohort before and during COVID-19.

RESULTS

The overall rates of in-hospital and 30-day death were 1.9% and 2.8%, respectively. The rate of 30-day death declined between 2017 (2.9%) and February 2020 (2.5%), mainly due to lower in-hospital death (2.1% vs 1.5%), before rising again from March 1, 2020 (3.2%) due to higher rates of postdischarge mortality. Only 59.6% of 30-day deaths were due to cardiac causes, with the most common causes being acute coronary syndrome, cardiogenic shock, and heart failure, and this persisted throughout the study period. In the 30-day death group, 10.4% after March 1, 2020 were due to confirmed COVID-19.

CONCLUSIONS

In this nationwide study, we show that 40% of 30-day deaths are due to non-cardiac causes. Non-cardiac deaths have increased even more from the start of the COVID-19 pandemic, with 1 in 10 deaths from March 2020 being COVID-19 related. These findings raise a question of whether public reporting of PCI outcomes should be cause specific.

摘要

背景

经皮冠状动脉介入治疗(PCI)结果的公开报告是一种绩效指标,也是许多医疗保健系统的要求。关于 PCI 后的死亡原因以及这些死亡中有多少归因于心脏原因的数据不一致。

方法

根据 PCI 后结局,回顾性分析 2017 年 1 月 1 日至 2020 年 5 月 10 日期间在英格兰接受 PCI 的所有患者:无死亡、院内死亡、出院后死亡和总 30 天死亡。本研究在 COVID-19 之前和期间检查了全国队列中 PCI 后短期主要死亡原因。

结果

总的院内和 30 天死亡率分别为 1.9%和 2.8%。30 天死亡率在 2017 年(2.9%)和 2020 年 2 月(2.5%)之间下降,主要是由于院内死亡率降低(2.1%比 1.5%),然后从 2020 年 3 月 1 日再次上升(3.2%),原因是出院后死亡率较高。只有 59.6%的 30 天死亡归因于心脏原因,最常见的原因是急性冠状动脉综合征、心源性休克和心力衰竭,这种情况在整个研究期间持续存在。在 30 天死亡组中,2020 年 3 月 1 日之后有 10.4%的死亡归因于确诊的 COVID-19。

结论

在这项全国性研究中,我们表明 30 天死亡中有 40%归因于非心脏原因。自 COVID-19 大流行开始以来,非心脏死亡甚至更多,自 2020 年 3 月以来,每 10 例死亡中就有 1 例与 COVID-19 相关。这些发现提出了一个问题,即 PCI 结果的公开报告是否应该针对具体病因。

相似文献

1
In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention in England in the Pre-COVID and COVID Eras.英格兰在新冠疫情前和疫情期间经皮冠状动脉介入治疗后的住院和 30 天死亡率。
J Invasive Cardiol. 2021 Mar;33(3):E206-E219. doi: 10.25270/jic/20.00639. Epub 2020 Dec 22.
2
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York.纽约在新冠疫情前后对 ST 段抬高型心肌梗死患者进行经皮冠状动脉介入治疗。
Am J Cardiol. 2021 Mar 1;142:25-34. doi: 10.1016/j.amjcard.2020.11.033. Epub 2020 Dec 8.
3
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.COVID-19 大流行与英格兰急性冠状动脉综合征的入院率及治疗管理。
Lancet. 2020 Aug 8;396(10248):381-389. doi: 10.1016/S0140-6736(20)31356-8. Epub 2020 Jul 14.
4
Causes of Mortality After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后的死亡原因
Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005355. doi: 10.1161/CIRCOUTCOMES.118.005355.
5
Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England.COVID-19 阳性急性冠状动脉综合征患者的结局:来自英国的多源电子医疗记录研究。
J Intern Med. 2021 Jul;290(1):88-100. doi: 10.1111/joim.13246. Epub 2021 Mar 13.
6
Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.癌症病史预示着急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后更差的急性和长期非心脏(而非心脏)死亡率。
Mayo Clin Proc. 2016 Dec;91(12):1680-1692. doi: 10.1016/j.mayocp.2016.06.029.
7
Effect of COVID-19 Pandemic Lockdown on Emergency Medical Service Utilisation, and Percutaneous Coronary Intervention Volume-An Australian Perspective.新冠疫情封锁对澳大利亚急诊医疗服务利用和经皮冠状动脉介入治疗量的影响
Heart Lung Circ. 2024 Aug;33(8):1151-1162. doi: 10.1016/j.hlc.2024.02.018. Epub 2024 Jul 2.
8
Should We Postpone Elective Cardiovascular Procedures and Percutaneous Coronary Interventions During the COVID-19 Pandemic?在 COVID-19 大流行期间,我们是否应该推迟择期心血管手术和经皮冠状动脉介入治疗?
Heart Surg Forum. 2021 Jan 15;24(1):E022-E030. doi: 10.1532/hsf.3385.
9
Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.经皮冠状动脉介入治疗并发心源性休克患者使用经皮左心室辅助装置的性别差异:来自经皮心室辅助装置工作组
Indian Heart J. 2018 Jul;70 Suppl 1(Suppl 1):S90-S95. doi: 10.1016/j.ihj.2018.04.009. Epub 2018 Apr 30.
10
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting.在强制性结果报告时代经皮冠状动脉介入治疗后 30 天内的死亡原因。
J Am Coll Cardiol. 2013 Jul 30;62(5):409-15. doi: 10.1016/j.jacc.2013.03.071. Epub 2013 May 9.

引用本文的文献

1
Impact of continuous care on cardiac function in patients with lung cancer complicated by coronary heart disease.持续护理对肺癌合并冠心病患者心脏功能的影响。
World J Clin Cases. 2024 Jan 16;12(2):314-321. doi: 10.12998/wjcc.v12.i2.314.
2
Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.与 2019 年冠状病毒病(COVID-19)大流行影响研究(COPES)相关的非 COVID 结局:系统评价和荟萃分析。
PLoS One. 2022 Jun 24;17(6):e0269871. doi: 10.1371/journal.pone.0269871. eCollection 2022.
3
The Impact of the COVID-19 Pandemic on Hospital Services for Patients with Cardiac Diseases: A Scoping Review.
COVID-19 大流行对心脏病患者医院服务的影响:范围综述。
Int J Environ Res Public Health. 2022 Mar 8;19(6):3172. doi: 10.3390/ijerph19063172.